CAPR: FDA Reviews BLA
Capricor Therapeutics announces FDA advisory committee meeting to review BLA for Deramiocel for Duchenne Muscular Dystrophy treatment
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.